Dr John Bolodeoku

Professional statement

Dr John Bolodeoku is a leading consultant chemical pathologist based in Basingstoke and London. With more than 25 years of experience in the medical field, Dr Bolodeoku is highly-experienced in chemical pathology. His areas of expertise include the management of cholesterol and diabetes, as well as pre-diabetes, thyroid disease and metabolic syndrome. 
 
Dr Bolodeoku received his MBBS from the University of Ibadan, Nigeria, before going on to receive a Doctor of Philosophy (DPhil) from the University of Oxford in 1996. He began his postgraduate medical career at St Helier Hospital, Carshalton and St Georges Hospital Medical School, London. He has worked in numerous hospitals across the UK since qualifying, and completed his specialist training in chemical pathology (UK-CCST) in 1998. He is also a fellow of the Royal College of Pathologists.
 
Mr Bolodeoku is currently a consultant chemical pathologist at the Candover Clinic at the Basingstoke and North Hampshire Hospital, and at Sterling Healthcare Group, New Malden Diagnostic Centre.  

In addition to his clinical work, Dr Bolodeoku is a leading voice in the pharmaceutical and medical consulting industry. He has served as chief executive officer for The EGCC, a leading global oncology-consulting firm. He has also served as chief medical officer for numerous pharmaceutical companies, including Innoture, Zeab Therapeutic Limited and A1 Labs.
 
Mr Bolodeoku is also a respected medical educator. He has held tutorials and lectures at both the undergraduate and postgraduate levels in esteemed institutions such as the University of London and King’s College London. He has also been involved in the examination of final-year MBBS students at the Royal Free Hospital Medical School. Mr Bolodeoku has published numerous medical articles in peer-reviewed scientific journals, and is a co-author of the textbook Pathology (Pathology Integrated).